Found: 101
Select item for more details and to access through your institution.
There Is More to Hemorrhagic Necrosis Than Tumor Necrosis Factor.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1991, v. 83, n. 12, p. 807
- By:
- Publication type:
- Article
In vivo optical imaging-guided targeted sampling for precise diagnosis and molecular pathology.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-01447-4
- By:
- Publication type:
- Article
CTLA-4 and PD-1 pathway blockade: combinations in the clinic.
- Published in:
- Frontiers in Oncology, 2015, v. 5, p. 1, doi. 10.3389/fonc.2014.00385
- By:
- Publication type:
- Article
Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29342-0
- By:
- Publication type:
- Article
Direct Economic Burden of High-Risk and Metastatic Melanoma in the Elderly.
- Published in:
- Applied Health Economics & Health Policy, 2009, v. 7, n. 1, p. 31, doi. 10.1007/BF03256140
- By:
- Publication type:
- Article
Optimization of a self antigen for presentation of multiple epitopes in cancer immunity.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Isoform specific anti-TGFβ therapy enhances antitumor efficacy in mouse models of cancer.
- Published in:
- Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-02773-z
- By:
- Publication type:
- Article
Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29342-0
- By:
- Publication type:
- Article
Keratoacanthomas associated with imatinib mesylate.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Blockade of surface-bound TGF-β on regulatory T cells abrogates suppression of effector T cell function in the tumor microenvironment.
- Published in:
- Science Signaling, 2017, v. 10, n. 494, p. 1, doi. 10.1126/scisignal.aak9702
- By:
- Publication type:
- Article
Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 4, p. 1180, doi. 10.1245/s10434-019-08099-9
- By:
- Publication type:
- Article
Selecting antigens for cancer vaccines.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 4, p. 328, doi. 10.1038/nbt.2174
- By:
- Publication type:
- Article
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido.
- Published in:
- Nature Medicine, 2011, v. 17, n. 9, p. 1094, doi. 10.1038/nm.2438
- By:
- Publication type:
- Article
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma.
- Published in:
- Annals of the New York Academy of Sciences, 2013, v. 1291, n. 1, p. 1, doi. 10.1111/nyas.12180
- By:
- Publication type:
- Article
Definite regression of cutaneous melanoma metastases upon addition of topical contact sensitizer diphencyprone to immune checkpoint inhibitor treatment.
- Published in:
- Experimental Dermatology, 2016, v. 25, n. 7, p. 553, doi. 10.1111/exd.13030
- By:
- Publication type:
- Article
Enhanced Responses to Tumor Immunization Following Total Body Irradiation Are Time-Dependent.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0082496
- By:
- Publication type:
- Article
Two Distinct Categories of Focal Deletions in Cancer Genomes.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0066264
- By:
- Publication type:
- Article
Altered Development of NKT Cells, γδ T Cells, CD8 T Cells and NK Cells in a PLZF Deficient Patient.
- Published in:
- PLoS ONE, 2011, v. 6, n. 9, p. 1, doi. 10.1371/journal.pone.0024441
- By:
- Publication type:
- Article
Detection of Intra-Tumor Self Antigen Recognition during Melanoma Tumor Progression in Mice Using Advanced Multimode Confocal/Two Photon Microscope.
- Published in:
- PLoS ONE, 2011, v. 6, n. 6, p. 1, doi. 10.1371/journal.pone.0021214
- By:
- Publication type:
- Article
Frequent MAGE Mutations in Human Melanoma.
- Published in:
- PLoS ONE, 2010, v. 5, n. 9, p. 1, doi. 10.1371/journal.pone.0012773
- By:
- Publication type:
- Article
Alphavirus Replicon Particles Expressing TRP-2 Provide Potent Therapeutic Effect on Melanoma through Activation of Humoral and Cellular Immunity.
- Published in:
- PLoS ONE, 2010, v. 5, n. 9, p. 1, doi. 10.1371/journal.pone.0012670
- By:
- Publication type:
- Article
Agonist Anti-GITR Monoclonal Antibody Induces Melanoma Tumor Immunity in Mice by Altering Regulatory T Cell Stability and Intra-Tumor Accumulation.
- Published in:
- PLoS ONE, 2010, v. 5, n. 5, p. 1, doi. 10.1371/journal.pone.0010436
- By:
- Publication type:
- Article
CTLA-4 Antibodies: New Directions, New Combinations.
- Published in:
- Oncology (08909091), 2014, p. 1
- By:
- Publication type:
- Article
Improving the Therapeutic Benefits of Ipilimumab.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 14, p. 1288
- By:
- Publication type:
- Article
Preclinical Efficacy of CTLA-4 Blockade for Cancer Treatment With a Focus on Melanoma.
- Published in:
- Oncology (08909091), 2008, v. 22, p. 13
- By:
- Publication type:
- Article
Addressing current challenges and future directions in immuno-oncology: expert perspectives from the 2017 NIBIT Foundation Think Tank, Siena, Italy.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 1, p. 1, doi. 10.1007/s00262-018-2285-y
- By:
- Publication type:
- Article
Immunity to melanoma: unraveling the relation of tumor immunity and autoimmunity.
- Published in:
- Oncogene, 2003, v. 22, n. 20, p. 3180, doi. 10.1038/sj.onc.1206462
- By:
- Publication type:
- Article
Pilot Trial of Arginine Deprivation Plus Nivolumab and Ipilimumab in Patients with Metastatic Uveal Melanoma.
- Published in:
- Cancers, 2022, v. 14, n. 11, p. 2638, doi. 10.3390/cancers14112638
- By:
- Publication type:
- Article
Proton Pump Inhibitor Use and Efficacy of Nivolumab and Ipilimumab in Advanced Melanoma.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092300
- By:
- Publication type:
- Article
APR-246 increases tumor antigenicity independent of p53.
- Published in:
- Life Science Alliance, 2024, v. 7, n. 1, p. 1, doi. 10.26508/lsa.202301999
- By:
- Publication type:
- Article
Heat-inactivated modified vaccinia virus Ankara boosts Th1 cellular and humoral immunity as a vaccine adjuvant.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00542-5
- By:
- Publication type:
- Article
Multiple pathways to tumor immunity and concomitant autoimmunity.
- Published in:
- Immunological Reviews, 2002, v. 188, n. 1, p. 122, doi. 10.1034/j.1600-065X.2002.18811.x
- By:
- Publication type:
- Article
Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 3, p. 690, doi. 10.1002/cam4.1356
- By:
- Publication type:
- Article
Phase II study of temozolomide plus pegylated interferon-alpha-2b for metastatic melanoma.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Phase II study of temozolomide plus pegylated interferon‐α‐2b for metastatic melanomaPresented in part at the 39th American Society of Clinical Oncology Annual Meeting in New Orleans, Louisiana, June 5‐8, 2004.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 11, p. 2445
- By:
- Publication type:
- Article
Temozolomide plus thalidomide in patients with brain metastases from melanoma: a phase II study.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Temozolomide plus thalidomide in patients with brain metastases from melanoma: A Phase II study.
- Published in:
- Cancer (0008543X), 2005, v. 103, n. 12, p. 2590
- By:
- Publication type:
- Article
Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.
- Published in:
- Cell Research, 2015, v. 25, n. 3, p. 399, doi. 10.1038/cr.2015.28
- By:
- Publication type:
- Article
Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.
- Published in:
- Cell Research, 2015, v. 25, n. 2, p. 208, doi. 10.1038/cr.2015.3
- By:
- Publication type:
- Article
In situ vaccination with defined factors overcomes T cell exhaustion in distant tumors.
- Published in:
- 2019
- By:
- Publication type:
- journal article
PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Intratumoral delivery of inactivated modified vaccinia virus Ankara (iMVA) induces systemic antitumor immunity via STING and Batf3-dependent dendritic cells.
- Published in:
- Science Immunology, 2017, v. 2, n. 11, p. 1, doi. 10.1126/sciimmunol.aal1713
- By:
- Publication type:
- Article
In-depth tissue profiling using multiplexed immunohistochemical consecutive staining on single slide.
- Published in:
- Science Immunology, 2016, v. 1, n. 1, p. 1, doi. 10.1126/sciimmunol.aaf6925
- By:
- Publication type:
- Article
Comparative study of immune response to local tumor destruction modalities in a murine breast cancer model.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1405486
- By:
- Publication type:
- Article
Induction of autoantibodies to syngeneic prostate-specific membrane antigen by xenogeneic vaccination.
- Published in:
- International Journal of Cancer, 2005, v. 116, n. 3, p. 415, doi. 10.1002/ijc.21014
- By:
- Publication type:
- Article
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity.
- Published in:
- Nature Communications, 2017, v. 8, n. 2, p. 14340, doi. 10.1038/ncomms14340
- By:
- Publication type:
- Article
Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis.
- Published in:
- Nature Communications, 2016, v. 7, n. 2, p. 10391, doi. 10.1038/ncomms10391
- By:
- Publication type:
- Article
Id1 suppresses anti-tumour immune responses and promotes tumour progression by impairing myeloid cell maturation.
- Published in:
- Nature Communications, 2015, v. 6, n. 4, p. 6840, doi. 10.1038/ncomms7840
- By:
- Publication type:
- Article
The hallmarks of successful anticancer immunotherapy.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 459, p. 1, doi. 10.1126/scitranslmed.aat7807
- By:
- Publication type:
- Article